Susquehanna International Group
EFTRW

Susquehanna International Group’s eFFECTOR Therapeutics, Inc. Warrant EFTRW Stock Holding History

Susquehanna International Group’s Portfolio EFTRW Stock Details EFTRW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-200,557
Closed -$241 – 13433
2024
Q2 		$241 Buy
200,557
+183,763
+1,094% +$6.34K ﹤0.01% 11898
2024
Q1 		$2.35K Buy
+16,794
New +$2.15K ﹤0.01% 11981
2021
Q3 		– Sell
-14,945
Closed -$15K – 13773
2021
Q2 		$15K Buy
+14,945
New +$12.1K ﹤0.01% 12432

Susquehanna International Group's EFTRW Position: Q3 2024 in Review

Susquehanna International Group sold out of eFFECTOR Therapeutics, Inc. Warrant (EFTRW) in Q3 2024, closing a stake of 200,557 shares — an estimated $241 sold.

Susquehanna International Group first reported a position in EFTRW in Q2 2021 and held it in 3 quarters. The position peaked at $15K in Q2 2021. 1 fund tracked by Wall St. Rank holds EFTRW as of Q3 2024.

  • Susquehanna International Group reported no remaining eFFECTOR Therapeutics, Inc. Warrant position as of Q3 2024 after selling out during the quarter.
  • Susquehanna International Group sold 200,557 eFFECTOR Therapeutics, Inc. Warrant shares in Q3 2024, an estimated $241.
  • Susquehanna International Group first reported a position in eFFECTOR Therapeutics, Inc. Warrant in Q2 2021 and held it in 3 quarters.
  • Susquehanna International Group's eFFECTOR Therapeutics, Inc. Warrant position peaked at $15K in Q2 2021.
  • 1 fund tracked by Wall St. Rank held eFFECTOR Therapeutics, Inc. Warrant as of Q3 2024.

Based on Susquehanna International Group's 13F filing for Q3 2024, filed 14 Nov 2024.